Does preoperative neutrophil-to-lymphocyte ratio have a value in predicting recurrence in bladder tumour after intravesical BCG treatment?

Basit Öğe Kaydı
dc.authoridCAMTOSUN, Ahmet/0000-0002-5390-9088
dc.authoridTopcu, Ibrahim/0000-0002-6526-0255
dc.authorwosidaltintas, ramazan/AAP-2348-2020
dc.authorwosidTopçu, ibrahim/ISV-2252-2023
dc.authorwosidCAMTOSUN, Ahmet/ABI-8300-2020
dc.authorwosidçelik, hüseyin/AAA-3033-2021
dc.authorwosidTopcu, Ibrahim/AAH-5502-2021
dc.contributor.authorCamtosun, Ahmet
dc.contributor.authorCelik, Huseyin
dc.contributor.authorAltintas, Ramazan
dc.contributor.authorTopcu, Ibrahim
dc.contributor.authorTasdemir, Cemal
dc.date.accessioned2024-08-04T20:42:55Z
dc.date.available2024-08-04T20:42:55Z
dc.date.issued2017
dc.departmentİnönü Üniversitesien_US
dc.description.abstractThe purpose of this study was to evaluate the prognostic value of the ratio of preoperative neutrophil to lymphocyte after intravesical BCG treatment in non-muscle invasive bladder cancer (NMIBC). The data of 89 patients, operated for urothelial carcinoma and treated with BCG after the diagnosis of NMIBC between 2007 and 2014, were reviewed retrospectively. Preoperative complete blood counts and first cystoscopic examination findings of the patients were examined. Median follow-up was 28.7 months. Tumour recurrence was detected in 33 patients (Group 2) of 89 patients. There was no tumour recurrence in 56 patients (Group 1). Neutrophil/lymphocyte ratio, MPV and CIS incidence were significantly increased in Group 2. This study showed that, preoperative high neutrophil/lymphocyte ratio, MPV and CIS occurrence can be used as independent criteria to predict tumour recurrence after intravesical BCG treatment in NMIBC.en_US
dc.identifier.endpage40en_US
dc.identifier.issn0970-938X
dc.identifier.issn0976-1683
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-85009999759en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage36en_US
dc.identifier.urihttps://hdl.handle.net/11616/97671
dc.identifier.volume28en_US
dc.identifier.wosWOS:000393483400006en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isoenen_US
dc.publisherScientific Publishers Indiaen_US
dc.relation.ispartofBiomedical Research-Indiaen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCanceren_US
dc.subjectLymphocyteen_US
dc.subjectBCGen_US
dc.subjectNeutrophilen_US
dc.subjectMPVen_US
dc.titleDoes preoperative neutrophil-to-lymphocyte ratio have a value in predicting recurrence in bladder tumour after intravesical BCG treatment?en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu